NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $59.95 -2.61 (-4.17 %) (As of 12/14/2018 04:00 PM ET)Previous Close$62.56Today's Range$59.23 - $61.8352-Week Range$51.88 - $112.25Volume387,100 shsAverage Volume472,202 shsMarket Capitalization$1.52 billionP/E Ratio11.03Dividend YieldN/ABeta0.47 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Magellan Health, Inc. provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers. It also contracts with local, state, and federal governmental agencies to provide services to recipients under Medicaid, Medicare, and other government programs, such as behavioral health and EAP, as well as healthcare management and long term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs, pharmaceutical dispensing services, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona. Receive MGLN News and Ratings via Email Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Hospitals Sub-IndustryManaged Health Care SectorMedical Current SymbolNASDAQ:MGLN Previous Symbol CUSIP55907920 Webwww.magellanhealth.com Phone602-572-6050 Debt Debt-to-Equity Ratio0.55 Current Ratio1.72 Quick Ratio1.67 Price-To-Earnings Trailing P/E Ratio11.03 Forward P/E Ratio16.61 P/E Growth1.73 Sales & Book Value Annual Sales$5.84 billion Price / Sales0.25 Cash Flow$10.1267 per share Price / Cash Flow5.92 Book Value$53.09 per share Price / Book1.13 Profitability EPS (Most Recent Fiscal Year)$5.50 Net Income$110.20 million Net Margins1.49% Return on Equity10.93% Return on Assets4.67% Miscellaneous Employees10,700 Outstanding Shares24,250,000Market Cap$1.52 billion OptionableOptionable Magellan Health (NASDAQ:MGLN) Frequently Asked Questions What is Magellan Health's stock symbol? Magellan Health trades on the NASDAQ under the ticker symbol "MGLN." How were Magellan Health's earnings last quarter? Magellan Health Inc (NASDAQ:MGLN) issued its quarterly earnings results on Wednesday, November, 7th. The company reported $1.45 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.17 by $0.28. The firm had revenue of $1.85 billion for the quarter, compared to analysts' expectations of $1.85 billion. Magellan Health had a return on equity of 10.93% and a net margin of 1.49%. Magellan Health's revenue was up 30.6% on a year-over-year basis. During the same quarter last year, the business posted $1.64 EPS. View Magellan Health's Earnings History. When is Magellan Health's next earnings date? Magellan Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Magellan Health. What guidance has Magellan Health issued on next quarter's earnings? Magellan Health issued an update on its FY19 earnings guidance on Friday, December, 7th. The company provided EPS guidance of $3.70-4.69 for the period, compared to the Thomson Reuters consensus estimate of $4.50. The company issued revenue guidance of $7.2-7.5 billion, compared to the consensus revenue estimate of $7.11 billion.Magellan Health also updated its FY 2019 guidance to $3.70-4.69 EPS. What price target have analysts set for MGLN? 2 brokers have issued 1-year price targets for Magellan Health's shares. Their predictions range from $70.00 to $72.00. On average, they anticipate Magellan Health's stock price to reach $71.00 in the next year. This suggests a possible upside of 18.4% from the stock's current price. View Analyst Price Targets for Magellan Health. What is the consensus analysts' recommendation for Magellan Health? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health. Has Magellan Health been receiving favorable news coverage? News coverage about MGLN stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Magellan Health earned a news sentiment score of 1.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of Magellan Health's key competitors? Some companies that are related to Magellan Health include MEDNAX (MD), Select Medical (SEM), Animalcare Group (ANCR), Capitol Health (CAJ), Healthscope (HSO), Medical Facilities (DR), Primary Health Care (PRY), Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Spine Injury Solutions (SPIN), SunLink Health Systems (SSY) and THC Biomed Intl (THC). Who are Magellan Health's key executives? Magellan Health's management team includes the folowing people: Mr. Barry Morgan Smith, Chairman & CEO (Age 64)Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 54)Mr. Daniel N. Gregoire, Gen. Counsel & Sec. (Age 62)Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 37)Ms. Renie Shapiro Silver, SVP - Corp. Fin. Who are Magellan Health's major shareholders? Magellan Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.51%), Vanguard Group Inc. (10.11%), Vanguard Group Inc (10.11%), FMR LLC (8.95%), Dimensional Fund Advisors LP (8.51%) and Renaissance Technologies LLC (4.13%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health. Which major investors are selling Magellan Health stock? MGLN stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, JPMorgan Chase & Co., JPMorgan Chase & Co., Wells Fargo & Company MN, Bank of Montreal Can, AXA, ClariVest Asset Management LLC and Nordea Investment Management AB. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Daniel N Gregoire, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health. Which major investors are buying Magellan Health stock? MGLN stock was acquired by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Morgan Stanley, Bridgeway Capital Management Inc., Assenagon Asset Management S.A., Brown Advisory Inc., BlackRock Inc., SG Americas Securities LLC and Man Group plc. View Insider Buying and Selling for Magellan Health. How do I buy shares of Magellan Health? Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Magellan Health's stock price today? One share of MGLN stock can currently be purchased for approximately $59.95. How big of a company is Magellan Health? Magellan Health has a market capitalization of $1.42 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe. What is Magellan Health's official website? The official website for Magellan Health is http://www.magellanhealth.com. How can I contact Magellan Health? Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected] MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 273 (Vote Outperform)Underperform Votes: 282 (Vote Underperform)Total Votes: 555MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/15/2018 by MarketBeat.com StaffFeatured Article: Does the discount rate affect the economy?